Global Pharmaceutical Packaging Report

Report Overview

Pharmaceutical Packaging Hits Its Next Growth Curve

The industry is shifting quickly as biologics, self-administration, and sustainability reshape which materials, formats, and regions lead demand. These changes are redefining competitive advantage for suppliers worldwide.

Key Themes Covered in this Report:

• Shift Toward Higher-Value Drug Delivery Formats: Biologics, self-administration, and unit-dose requirements are steering demand toward prefillable syringes, inhalers, pouches, and other specialized systems.
• Material Competition & Sustainability Pressure: Glass, plastics, and paper are all being reshaped by barrier needs, recyclability expectations, and cost volatility, changing how suppliers position their portfolios.
• Regional Realignment of Demand Growth: North America accelerates, Western Europe steadies, and Asia/Pacific normalizes – resetting the competitive landscape for global packaging producers.

The global pharmaceutical packaging market reached $71.3 billion in 2025 and is projected to grow 4.7% per year, reaching $89.7 billion in 2030. Several market forces are driving this sustained expansion:

• Ongoing expansion of drug production – particularly advanced therapies and vaccines – is driving demand for higher-value packaging and accelerating shifts to unit dose formats for safety, compliance, and efficiency.
• Intensifying regulatory, traceability, and anti-counterfeiting requirements are fueling investment in premium packaging materials, technologies, and features that ensure product security and support patient adherence.
• Central and South America, along with the Africa/Mideast region, will grow a at the fastest rates, driven by the continued development of pharmaceuticals production in these regions.

Compliance & Safety Drive Uptake of Advanced Packaging

The global push for improved patient safety, compliance, and anti-counterfeiting is reshaping the packaging landscape. Unit dose formats – including blister packs, prefillable syringes, and parenteral vials – are gaining share, as regulations in Europe and other developed regions mandate safer, more accountable dispensing. Technologies supporting traceability, tamper evidence, and medication adherence are now standard requirements for leading drug makers. Packaging suppliers able to deliver enhanced barrier properties, smart labeling, and child-resistant designs are best positioned for growth, especially as new biologic therapies and vaccines require sophisticated container solutions.

Material Innovation & Sustainability Underpin Long-Term Value

Plastics continue to account for the majority of packaging demand due to versatility and cost advantages, but glass packaging is set for stronger growth, driven by increased injectable drug and vaccine use. Efforts to improve sustainability – through lightweighting, recyclability, and renewable content – are gradually reshaping secondary and shipping containers, though strict safety and barrier standards still anchor plastics and glass for primary uses. Suppliers are introducing new materials and features to address waste reduction and regulatory pressure, but widespread material change will remain incremental.

Regional & Competitive Shifts Reshape the Market Landscape

While Western Europe, North America, and Asia/Pacific collectively represent the largest share of global demand, Central and South America and the Africa/Mideast region will grow at the fastest rates in value terms, supported by local drug production and growing exports. Globally, strategic acquisitions and partnerships continue to create a handful of diversified leaders, while local and regional suppliers continue to fill niche and emerging market needs. Going forward, the most successful companies will be those able to balance regulatory compliance, innovation, and supply chain flexibility as healthcare markets evolve.

Global Pharmaceutical Packaging Report Details

Leading Companies Driving Trends in the Pharmaceutical Packaging Industry

Pharmaceutical Packaging Formats

Factors that determine the mix of packaging for pharmaceuticals include cost and product performance, though regulatory compliance is becoming increasingly important.

Traditional packaging such as bottles and jars used with tablets, capsules, and ointments will continue to account for the largest share of global pharmaceutical packaging demand, with over 40% of overall value demand in 2025. This market leadership is due primarily to their entrenched usage, ease-of-use, capacity to comply with government regulations with features such as child-safety locks, and relative low cost compared to more advanced formats.

However, more specialized formats – vials, ampoules, syringes, and cartridges, among others – will continue to gain share, owing primarily to the expanding market of injectable pharmaceuticals, particularly in advanced economies. These formats benefit from their suitability for biologics, vaccines, and other parenteral therapies that require high levels of purity and precision in dosing. Growth will also be supported by the rising prevalence of chronic conditions treated with injectables, and the increasing adoption of self-administration devices that demand secure, high-performance primary packaging.

Global Pharmaceutical Packaging Report Scope

This detailed study examines the global market for pharmaceutical packaging. Among the specific products analyzed are:

• bottles and jars, which include standard plastic bottles, dispensing plastic bottles, plastic jars, plastic canisters, and glass bottles and jars
• blister packaging, which encompasses compartment packs, slide packs, and wallet packs
• prefillable syringes (injectors and cartridge holders)
• parenteral vials and ampoules, including both glass and plastic types
• IV containers (semi-rigid plastic IV containers, flexible IV bags & minibags, and glass IV containers)
• boxes and cartons (folding boxes and cartons, setup boxes, and corrugated shipping containers
• pouches, including paper, plastic, and foil types
• tubes, including composite tubes, plastic tubes, and collapsible metal tubes
• other packaging:
  • strip packs
  • all other packaging, including aerosol containers, clamshell packs, compartment pill holders and dispensers, composite and metal cans, foil and plastic cups, metal and plastic tins, plastic bags, plastic sprayer packets, plastic stick tubes, thermoformed trays

Pharmaceutical caps and closures, labels, and packaging accessories are excluded unless otherwise stated.